IGSF8 is an innate immune checkpoint and cancer immunotherapy target-Reference-Cited by-同舟云学术

IGSF8 is an innate immune checkpoint and cancer immunotherapy target

Published:2024-05 Issue:11 Volume:187 Page:2703-2716.e23
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Li Yulong,Wu Xiangyang,Sheng Caibin,Liu Hailing,Liu Huizhu,Tang Yixuan,Liu Chao,Ding Qingyang,Xie Bin,Xiao Xi,Zheng Rongbin,Yu Quan,Guo Zengdan,Ma Jian,Wang Jin,Gao Jinghong,Tian Mei,Wang Wei,Zhou Jia,Jiang Li,Gu Mengmeng,Shi Sailing,Paull Michael,Yang Guanhua,Yang Wei,Landau Steve,Bao Xingfeng,Hu Xihao,Liu X. Shirley,Xiao Tengfei^ORCID

Publisher

Elsevier BV

Reference85 articles.

1. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs;Haslam;JAMA Netw. Open,2019

2. Innate and adaptive immune cells in the tumor microenvironment;Gajewski;Nat. Immunol.,2013

3. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response;Jiang;Nat. Med.,2018

4. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade;Pauken;Science,2016

5. Chromatin states define tumour-specific T cell dysfunction and reprogramming;Philip;Nature,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8+ T cell exhaustion;Journal of Nanobiotechnology;2024-09-14

2. The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways;Cell Communication and Signaling;2024-08-19

3. RNA Isoforms as Broad Targets for Cancer Immunotherapy;DNA and Cell Biology;2024-08-01

4. An Improved Two-Shot Tracking Algorithm for Dynamics Analysis of Natural Killer Cells in Tumor Contexts;Bioengineering;2024-05-24